SCHEMBL8046136

SCHEMBL8046136

Cc1ccc(S(=O)(=O)CNC(=O)C(=O)[C@@H]2CCCCCCCCCCC(NCOC(C)(C)C)C(=O)N3C[C@H]4C(C3C(=O)N2)C4(C)C)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12606620 0.89 PLG (0.32) —
SCHEMBL13685239 0.89 PLG (0.32) —
SCHEMBL13685131 0.89 PLG (0.32) —
SCHEMBL16298035 0.89 PLG (0.32) —
SCHEMBL12606593 0.89 PLG (0.32) —
SCHEMBL13685095 0.89 PLG (0.32) —
SCHEMBL12606591 0.74 BACE1 (0.35) —
SCHEMBL13685200 0.74 BACE1 (0.35) —
SCHEMBL13685100 0.74 F2 (0.33) —
SCHEMBL12607798 0.70 BACE1 (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009058856-A1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE SCHERING CORPORATION (US) 2009-05-07 — — WO disclosed
Send feedback